Drug or treatment
Marstacimab clinical trials
As of November 12, 2026, Find a Trial lists 5 clinical trials of Marstacimab that are recruiting, at sites in 28 countries (most in United States (4), China (3), India (3)). 1 was first registered in the last 30 days. By phase: Phase 3 (3), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1New in 30 days
- 28Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Marstacimab for mild to moderate hemophilia A or B in people without inhibitors | Phase 3 | Flowood, Mississippi | Recruiting | Nov 9, 2026 |
| Marstacimab experiences in adolescents and adults with hemophilia | — | Xiamen, Fujian and 1 other locations | Recruiting | May 28, 2025 |
| Switching from Emicizumab to Marstacimab in Severe Hemophilia A | Phase 1 | La Jolla, California and 9 other locations | Recruiting | Nov 25, 2024 |
| Testing marstacimab for treating hemophilia in children | Phase 3 | Salt Lake City, Utah and 62 other locations | Recruiting | Nov 10, 2022 |
| Long-term treatment with marstacimab for hemophilia patients | Phase 3 | Iowa City, Iowa and 77 other locations | Recruiting | Dec 6, 2021 |
All recruiting trials (5)
-
Marstacimab for mild to moderate hemophilia A or B in people without inhibitors
This study tests whether weekly injections of marstacimab can reduce bleeding in adolescents and adults with mild to moderate hemophilia A or B who don’t have inhibitors.
-
Marstacimab experiences in adolescents and adults with hemophilia
This registry will collect experiences from adolescents and adults with hemophilia who are receiving marstacimab to see if they prefer subcutaneous injections and to track treatment burden and bleeding rates.
-
Switching from Emicizumab to Marstacimab in Severe Hemophilia A
This study is testing if switching from emicizumab to marstacimab is safe and how well the body handles the new medication in people with severe hemophilia A.
-
Testing marstacimab for treating hemophilia in children
This study is testing a new medication called marstacimab to see if it can help children with severe hemophilia control their bleeding and improve their health.
-
Long-term treatment with marstacimab for hemophilia patients
This study is testing a long-term treatment called marstacimab to see if it can safely help people with severe hemophilia A or B manage their condition better.
Quick answers
How many clinical trials of Marstacimab are recruiting right now?
5, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 28 countries. The most sites are in United States (4 trials), China (3 trials), India (3 trials), Turkey (Türkiye) (3 trials), Argentina (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.